Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
Nevada Governor Joe Lombardo Named BIO’s Governor…
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
BIO Supports PDUFA VIII Commitment Letter and…
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…
BIO Statement on Senate Reintroduction of the…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
All Press Releases
  • Show All
Search
Event Tags
August 31, 2026
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
August 13, 2026
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…
June 24, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
June 22, 2026
20,000+ biotech leaders gather with a shared mission: to improve lives  SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today…
May 22, 2026
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
May 12, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
April 15, 2026
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
April 2, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
March 17, 2026
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
March 2, 2026
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…